BioAegis Therapeutics

BioAegis Therapeutics BioAegis is a clinical stage biotechnology company commercializing ground breaking medical discoveries in inflammation and infection.

The company is currently conducting a Phase2 trial of recombinant human plasma gelsolin (rhu-pGSN) in COVID-19 patients.

Address

675 US Highway One
North Brunswick, NJ
08902

Alerts

Be the first to know and let us send you an email when BioAegis Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BioAegis Therapeutics:

Shortcuts

Share